StudyImprovementRR · 95% CITreatmentControlRelative Risk
Late treatment70%0.30 · 0.09–1.063/10310/10370% lower risk
Tau² = 0.00, I² = 0.0%, p = 0.061
All studies70%0.30 · 0.09–1.063/10310/10370% lower risk
Tau² = 0.00, I² = 0.0%, p = 0.06100.511.52+
Rotate screen for more detailsIncrease width for more details
← Levilimab
reduces riskLevilimab
increases risk →